086849345	086849345	CD	B-NP	O
|	|	NN	I-NP	O
NHC	NHC	NN	I-NP	O
|	|	NN	I-NP	O
45107454	45107454	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6226845	6226845	CD	B-NP	O
|	|	CC	I-NP	O
7/10/2004	7/10/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Atypical	Atypical	JJ	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/8/2004	7/8/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/26/2004	11/26/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
TREMPER	TREMPER	NN	B-NP	O
,	,	,	O	O
GARRET	GARRET	NN	B-NP	O
546-35-72-6	546-35-72-6	CD	I-NP	O
Ce	Ce	NNP	I-NP	O
Iant	Iant	NNP	I-NP	O
Ette	Ette	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
3/6/04	3/6/04	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Home	Home	NNP	I-NP	O
services	service	NNS	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KETTERER	KETTERER	NNP	B-NP	O
,	,	,	O	O
WINSTON	WINSTON	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
CPR	CPR	NN	I-NP	B-protein
/	/	SYM	B-NP	O
No	No	NN	I-NP	O
defib	defib	NN	I-NP	O
/	/	SYM	B-NP	O
No	No	NN	I-NP	O
intubation	intubation	NN	I-NP	O
/	/	SYM	B-NP	O
No	No	NN	I-NP	B-protein
CPR	CPR	NN	I-NP	I-protein
/	/	SYM	B-NP	O
No	No	NN	I-NP	O
intubation	intubation	NN	I-NP	O
/	/	SYM	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-protein
100	100	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QOD	QOD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/18/04	3/18/04	CD	B-NP	O
by	by	IN	B-PP	O
HAMISS	HAMISS	NN	B-NP	O
,	,	,	O	O
HORACE	HORACE	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
33066339	33066339	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/18/04	3/18/04	CD	B-NP	O
by	by	IN	B-PP	O
LANDUCCI	LANDUCCI	NN	B-NP	O
,	,	,	O	O
GALEN	GALEN	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
69454879	69454879	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
.	.	.	O	O

LASIX	LASIX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/29	7/29	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/16/04	9/16/04	CD	B-NP	O
by	by	IN	B-PP	O
BLAILOCK	BLAILOCK	NN	B-NP	O
,	,	,	O	O
BARNEY	BARNEY	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
67068161	67068161	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
SULFISOXAZOLE	SULFISOXAZOLE	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
g6pd	g6pd	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
G6PD	G6PD	NN	B-NP	O
Deficiency	Deficiency	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
G6PD	G6PD	NN	B-NP	O
DEFICIENCY	DEFICIENCY	NN	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
.	.	.	O	O

takes	take	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
25	25	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/18/04	3/18/04	CD	B-NP	O
by	by	IN	B-PP	O
KENRICK	KENRICK	NN	B-NP	O
,	,	,	O	O
FREEMAN	FREEMAN	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
33066339	33066339	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/18/04	3/18/04	CD	B-NP	O
by	by	IN	B-PP	O
DESAK	DESAK	NN	B-NP	B-protein
,	,	,	O	O
CARSON	CARSON	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
69454879	69454879	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
.	.	.	O	O

NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
SL	SL	NN	I-NP	I-protein
q5min	q5min	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
TRAZODONE	TRAZODONE	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
HS	HS	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Insomnia	Insomnia	NNP	I-NP	I-protein
COUMADIN	COUMADIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
WARFARIN	WARFARIN	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
3	3	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/3	2/3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
QMWF	QMWF	NNP	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/18/04	3/18/04	CD	B-NP	O
by	by	IN	B-PP	O
LUELLEN	LUELLEN	NNP	B-NP	O
,	,	,	O	O
ABRAHAM	ABRAHAM	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
.	.	.	O	O

COUMADIN	COUMADIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/3	2/3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
QTTSS	QTTSS	NNP	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/18/04	3/18/04	CD	B-NP	O
by	by	IN	B-PP	O
FEIGHAN	FEIGHAN	NNP	B-NP	O
,	,	,	O	O
THEO	THEO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
.	.	.	O	O

ZOCOR	ZOCOR	NN	B-NP	B-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/18/04	3/18/04	CD	B-NP	O
by	by	IN	B-PP	O
ATHMANN	ATHMANN	NN	B-NP	O
,	,	,	O	O
KIP	KIP	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
33066339	33066339	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/18/04	3/18/04	CD	B-NP	O
by	by	IN	B-PP	O
STRUTYNSKI	STRUTYNSKI	NN	B-NP	O
,	,	,	O	O
JOE	JOE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
69454879	69454879	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
.	.	.	O	O

IMDUR	IMDUR	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONIT	MONONIT	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
SR	SR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DIOVAN	DIOVAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC+HS	AC+HS	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
1/2	1/2	CD	B-NP	O
doses	dose	NNS	I-NP	O
while	while	IN	B-SBAR	O
NPO	NPO	NN	B-NP	B-protein
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
42	42	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
Npo	Npo	NNP	B-NP	B-protein
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SUST	SUST	NNP	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

150	150	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

PROTONIX	PROTONIX	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PROCRIT	PROCRIT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EPOETIN	EPOETIN	NNP	I-NP	O
ALFA	ALFA	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4	4	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
IRON	IRON	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Bente	Bente	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Jerrod	Jerrod	NNP	I-NP	O
Petteway	Petteway	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
1/6/04	1/6/04	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
DRAIN	DRAIN	NN	B-NP	O
CLINIC	CLINIC	NN	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
clinic	clinic	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
PERCOCET	PERCOCET	NN	B-NP	O
,	,	,	O	O
METOCLOPRAMIDE	METOCLOPRAMIDE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
SULFISOXAZOLE	SULFISOXAZOLE	NNP	B-NP	O
,	,	,	O	O
Cephalosporins	Cephalosporins	NNP	B-NP	O
,	,	,	O	O
G6PD	G6PD	NNP	B-NP	O
Deficiency	Deficiency	NNP	I-NP	O
,	,	,	O	O
Aspirin	Aspirin	NNP	B-NP	O
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
,	,	,	O	O
NALIDIXIC	NALIDIXIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
,	,	,	O	O
LESTRILL	LESTRILL	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
METRONIDAZOLE	METRONIDAZOLE	NNP	B-NP	O
,	,	,	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NNP	B-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
LIDOCAINE	LIDOCAINE	NNP	B-NP	O
,	,	,	O	O
TETRACYCLINES	TETRACYCLINES	NNP	B-NP	O
,	,	,	O	O
clindamycin	clindamycin	NN	B-NP	O
,	,	,	O	O
CARROTS	CARROTS	NN	B-NP	O
,	,	,	O	O
CELERY	CELERY	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Atypical	Atypical	NNP	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Asthma	Asthma	NNP	I-NP	O
HTN	HTN	NN	I-NP	O
RAD	RAD	NN	I-NP	O
G6PD	G6PD	NN	I-NP	O
DEF	DEF	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
h/o	h/o	NN	I-NP	O
ischemic	ischemic	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
Arthritis	Arthritis	NN	I-NP	O
DJD	DJD	NN	I-NP	O
Allergic	Allergic	JJ	I-NP	O
rhinitis	rhinitis	NN	I-NP	O
Glaucoma	Glaucoma	NN	I-NP	O
Bursitis	Bursitis	NN	I-NP	O
S/P	S/P	NN	I-NP	O
appy	appy	JJ	B-ADJP	O
,	,	,	O	O
TAH	TAH	NN	B-NP	B-protein
,	,	,	O	O
Zenker	Zenker	NNP	B-NP	O
's	's	POS	B-NP	O
divertic	divertic	JJ	I-NP	O
removal	removal	NN	I-NP	O
hx	hx	NN	I-NP	O
dvt	dvt	NN	I-NP	O
1988	1988	CD	I-NP	O
obstructive	obstructive	JJ	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
Diastolic	Diastolic	JJ	I-NP	O
Dysfunction	Dysfunction	NN	I-NP	O
gout	gout	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2-stage	2-stage	JJ	I-NP	O
pharmacologic	pharmacologic	JJ	I-NP	O
MIBI	MIBI	NN	I-NP	O
;	;	:	O	O
echocardiogram	echocardiogram	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
76	76	CD	B-NP	O
y/o	y/o	NN	I-NP	O
AAF	AAF	NN	I-NP	O
with	with	IN	B-PP	O
mutiple	mutiple	JJ	B-NP	O
med	me	VBN	B-VP	O
.	.	.	O	O

problems	problem	NNS	B-NP	O
including	include	VBG	B-PP	O
,	,	,	O	O
DM2	DM2	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
dystolic	dystolic	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
base	base	NN	I-NP	I-protein
1.9	1.9	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
colitis	colitis	NN	I-NP	O
,	,	,	O	O
DVT	DVT	NN	B-NP	O
,	,	,	O	O
hyperchol	hyperchol	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
G6PD	G6PD	NN	B-NP	B-protein
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Describes	Describe	NNS	B-NP	O
pain	pain	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
8/10	8/10	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
as	as	IN	B-PP	O
mid	mid	JJ	B-NP	O
chest	chest	NN	I-NP	O
and	and	CC	I-NP	O
b/l	b/l	NN	I-NP	O
;	;	:	O	O
feels	feel	NNS	B-NP	O
like	like	IN	B-PP	O
pressure	pressure	NN	B-NP	O
.	.	.	O	O

Associated	Associate	VBN	B-VP	O
with	with	IN	B-PP	O
numbness	numbness	NN	B-NP	O
radiating	radiate	VBG	B-VP	O
down	down	IN	B-PP	O
medial	medial	JJ	B-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
L	L	NN	B-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
reports	report	NNS	I-NP	O
Nitro	Nitro	NNP	B-NP	O
helped	help	VBD	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
2	2	CD	B-NP	O
tabs	tab	NNS	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Exertion	Exertion	NN	B-NP	O
makes	make	VBZ	B-VP	O
pain	pain	NN	B-NP	O
worse	worse	JJR	B-ADJP	O
but	but	CC	O	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
happen	happen	VB	I-VP	O
at	at	IN	B-PP	O
rest.associated	rest.associate	VBN	B-VP	O
with	with	IN	B-PP	O
naseua	naseua	NN	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
+	+	CC	O	O
white	white	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	I-NP	O
DOE	DOE	NNP	I-NP	O
,	,	,	I-NP	O
orthopnea	orthopnea	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
3	3	CD	I-NP	I-protein
pillows	pillow	NNS	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
PND	PND	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
or	or	CC	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
diet	diet	NN	B-NP	O
reported	report	VBD	B-VP	O
.	.	.	O	O

has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
missed	miss	VBN	I-VP	O
med	me	VBN	B-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
PCP	PCP	NN	B-NP	O
today	today	NN	B-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
NGT	NGT	NN	B-NP	B-protein
tabs	tab	NNS	I-NP	I-protein
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
resolve	resolve	VB	I-VP	O
all	all	DT	B-NP	O
pain	pain	NN	I-NP	O
;	;	:	O	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
ER	ER	NN	B-NP	B-protein
for	for	IN	B-PP	O
eval	eval	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
,	,	,	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
stable	stable	JJ	B-ADJP	O
;	;	:	O	O
first	first	JJ	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
wnl	wnl	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
shows	show	VBZ	B-VP	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
more	more	JJR	B-NP	O
nitro	nitro	NN	I-NP	O
in	in	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
.	.	.	O	O

Meds	Med	NNS	B-NP	O
:	:	:	O	O
PPI	PPI	NN	B-NP	B-protein
,	,	,	O	O
lantus	lantus	NN	B-NP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
,	,	,	O	O
valsartan	valsartan	NN	B-NP	O
,	,	,	O	O
procrit	procrit	NN	B-NP	O
,	,	,	O	O
levothy	levothy	NN	B-NP	O
,	,	,	O	O
toporol	toporol	NN	B-NP	O
,	,	,	O	O
SSI	SSI	NN	B-NP	O
,	,	,	O	O
imdur	imdur	NN	B-NP	O
,	,	,	O	O
NTG	NTG	NN	B-NP	B-protein
.	.	.	O	O

coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
FE	FE	NN	B-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
,	,	,	O	O
trazadone	trazadone	NN	B-NP	O
.	.	.	O	O

ALL	ALL	NN	B-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
codine	codine	NN	B-NP	O
,	,	,	O	O
metochloprazide	metochloprazide	NN	B-NP	O
,	,	,	O	O
sulfas	sulfas	NN	B-NP	O
,	,	,	O	O
clinda	clinda	NN	B-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
,	,	,	O	O
cephlasporins	cephlasporin	NNS	B-NP	O
,	,	,	O	O
metronidazole	metronidazole	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
amitryptline	amitryptline	NN	B-NP	O
,	,	,	O	O
lidocaine	lidocaine	NN	B-NP	O
,	,	,	O	O
tetracycline	tetracycline	NN	B-NP	O
,	,	,	O	O
carrots	carrot	NNS	B-NP	O
,	,	,	O	O
celery	celery	NN	B-NP	O
,	,	,	O	O
lestril	lestril	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
.	.	.	O	O

PSH	PSH	NN	B-NP	O
:	:	:	O	O
Cath	Cath	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
stent	stent	NN	I-NP	O
,	,	,	O	O
append	append	NN	B-NP	O
.	.	.	O	O

Soc	Soc	NN	B-NP	B-protein
:	:	:	O	O
No	No	DT	B-NP	O
tobacco/etoh/drugs	tobacco/etoh/drug	NNS	I-NP	O
Fam	Fam	NNP	B-NP	O
Hx	Hx	NNP	I-NP	O
:	:	:	O	O
ext	ext	JJ	B-NP	O
DM2	DM2	NN	I-NP	O
and	and	CC	I-NP	O
HTN	HTN	NN	I-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
vitals	vital	NNS	B-NP	O
afebrile	afebrile	JJ	B-NP	O
and	and	CC	I-NP	O
stable	stable	JJ	I-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
eld	eld	NN	I-NP	O
.	.	.	O	O

female	female	JJ	B-ADJP	O
with	with	IN	B-PP	O
incr	incr	NN	B-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	I-NP	O
9	9	CD	I-NP	O
cm	cm	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
s3	s3	NN	B-NP	B-protein
,	,	,	O	O
diffuse	diffuse	JJ	B-NP	O
end	end	NN	I-NP	O
exp	exp	NN	I-NP	O
wheezes	wheeze	VBZ	B-VP	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
,	,	,	O	O
umb	umb	NN	B-NP	O
.	.	.	O	O

hernia	hernia	NN	B-NP	O
and	and	CC	I-NP	O
3	3	CD	I-NP	O
+	+	SYM	I-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	O
:	:	:	O	O
Enzymes	Enzyme	NNS	B-NP	B-protein
and	and	CC	O	O
EKG	EKG	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
negative	negative	JJ	I-NP	O
Hosptial	Hosptial	JJ	I-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
76	76	CD	B-NP	O
y/o	y/o	NN	I-NP	O
AAF	AAF	NN	I-NP	O
with	with	IN	B-PP	O
mutiple	mutiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
extensive	extensive	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
history	history	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
DOE	DOE	NNP	B-NP	O
and	and	CC	O	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Likely	Likely	RB	B-NP	O
diastolic	diastolic	JJ	I-NP	O
CHF	CHF	NN	I-NP	O
although	although	IN	B-SBAR	O
ischemic	ischemic	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
issues	issue	NNS	I-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	I-NP	O
pump	pump	NN	I-NP	O
:	:	:	O	O
clinical	clinical	JJ	B-NP	O
picture	picture	NN	I-NP	O
c/w	c/w	NN	I-NP	O
diastolic	diastolic	JJ	I-NP	O
CHF	CHF	NN	I-NP	O
.	.	.	O	O

Echo	Echo	RB	B-NP	O
1/25	1/25	CD	I-NP	O
sho	sho	NN	I-NP	O
wed	wed	VBD	B-VP	O
EF	EF	NN	B-NP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
concentric	concentric	JJ	I-NP	O
LVH	LVH	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
Lasix	Lasix	NNP	B-NP	O
160mg	160mg	NN	I-NP	O
iv	iv	JJ	I-NP	O
bid	bid	NN	I-NP	O
with	with	IN	B-PP	O
I/O	I/O	NN	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
1-2L	1-2L	NN	B-NP	O
neg	neg	NN	I-NP	O
/	/	SYM	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

strict	strict	JJ	B-NP	O
I/O	I/O	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
g	g	NN	I-NP	O
NA	NA	NN	I-NP	O
and	and	CC	O	O
2L	2L	NN	B-NP	O
fluid	fluid	NN	I-NP	O
restrict	restrict	NN	I-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
DOE	DOE	NN	I-NP	O
significantly	significantly	RB	B-VP	O
improved	improve	VBN	I-VP	O
after	after	IN	B-PP	O
agressive	agressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
120mg	120mg	CD	B-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
on	on	IN	B-PP	O
d	d	NN	B-NP	O
ischarge	ischarge	NN	I-NP	O
.	.	.	O	O

Ischemia-MIBI	Ischemia-MIBI	NN	B-NP	O
on	on	IN	B-PP	O
2/3	2/3	NN	B-NP	O
showed	show	VBD	B-VP	O
EF	EF	NN	B-NP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
RV	RV	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
tele	tele	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
-	-	HYPH	I-NP	O
nebs	neb	NNS	I-NP	O
prn	prn	VBP	B-VP	O
for	for	IN	B-PP	O
wheezing	wheeze	VBG	B-VP	O
though	though	IN	B-SBAR	O
likely	likely	RB	B-ADJP	O
cardiac	cardiac	JJ	I-ADJP	O
rather	rather	RB	B-PP	O
than	than	IN	I-PP	O
bronchospastic	bronchospastic	JJ	B-ADJP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
-	-	HYPH	I-NP	O
check	check	NN	I-NP	O
lytes	lyte	NNS	I-NP	O
BID	BID	NN	I-NP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GI	GI	NN	B-NP	O
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
PPI	PPI	NN	B-NP	B-protein
for	for	IN	B-PP	O
GI	GI	NN	B-NP	O
protection	protection	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
for	for	IN	B-PP	O
A-fib	A-fib	NN	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
goal	goal	NN	I-NP	O
2-3	2-3	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Endo	Endo	AFX	B-NP	B-protein
-	-	HYPH	I-NP	O
cont	cont	JJ	B-NP	O
lantus	lantus	NN	I-NP	O
with	with	IN	B-PP	O
SSI	SSI	NN	B-NP	O
for	for	IN	B-PP	O
DM2	DM2	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Code	Code	NNP	B-NP	O
:	:	:	O	O
CAN	CAN	NN	B-NP	O
defibrillate	defibrillate	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
CPR	CPR	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
DNI	DNI	NN	B-NP	B-protein
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
If	If	IN	B-SBAR	O
your	your	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
recur	recur	VBP	B-VP	O
or	or	CC	I-VP	O
worsen	worsen	VBP	I-VP	O
,	,	,	O	O
please	please	VB	B-VP	O
seek	seek	JJ	B-NP	O
medical	medical	JJ	I-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

Avoid	Avoid	JJ	B-NP	O
salt	salt	NN	I-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
make	make	VB	I-VP	O
followup	followup	NN	B-NP	O
appointments	appointment	NNS	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Westgaard	Westgaard	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Schaunt	Schaunt	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Satisfactory	Satisfactory	JJ	B-ADJP	O
TO	TO	TO	B-VP	O
DO/PLAN	DO/PLAN	NN	I-VP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Please	Please	NN	I-NP	O
schedule	schedule	NN	I-NP	O
followup	followup	NN	I-NP	O
appointments	appointment	NNS	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Samaan	Samaan	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Prinzing	Prinzing	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
1-2	1-2	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
have	have	VBP	B-VP	O
blood	blood	NN	B-NP	O
test	test	NN	I-NP	O
for	for	IN	B-PP	O
chem7	chem7	NN	B-NP	O
and	and	CC	I-NP	O
magnesium	magnesium	NN	I-NP	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Woolen	Woolen	NNP	I-NP	O
discuss	discuss	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sloma	Sloma	NNP	I-NP	O
about	about	IN	B-PP	O
your	your	PRP$	B-NP	O
Lasix	Lasix	NNP	I-NP	O
dose	dose	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SCIALLO	SCIALLO	NNP	B-NP	O
,	,	,	O	O
RENALDO	RENALDO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FO69	FO69	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/21/04	5/21/04	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
39	39	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

